SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-22-003197
Filing Date
2022-05-11
Accepted
2022-05-11 16:22:56
Documents
60
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q vnrx_10q.htm   iXBRL 10-Q 992721
2 LICENSE AND SUPPLY AGREEMENT vnrx_ex101.htm EX-10.1 178256
3 CERTIFICATION vnrx_ex311.htm EX-31.1 11802
4 CERTIFICATION vnrx_ex312.htm EX-31.2 12375
5 CERTIFICATION vnrx_ex321.htm EX-32.1 4904
  Complete submission text file 0001477932-22-003197.txt   5396948

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vnrx-20220331.xsd EX-101.SCH 61867
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE vnrx-20220331_lab.xml EX-101.LAB 352083
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vnrx-20220331_cal.xml EX-101.CAL 45245
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vnrx-20220331_pre.xml EX-101.PRE 291379
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vnrx-20220331_def.xml EX-101.DEF 195958
54 EXTRACTED XBRL INSTANCE DOCUMENT vnrx_10q_htm.xml XML 816722
Mailing Address 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738
Business Address 13215 BEE CAVE PARKWAY, SUITE 125, GALLERIA OAKS B AUSTIN TX 78738 1 (646) 650-1351
VOLITIONRX LTD (Filer) CIK: 0000093314 (see all company filings)

IRS No.: 911949078 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36833 | Film No.: 22914108
SIC: 2835 In Vitro & In Vivo Diagnostic Substances